Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndrome

Use of agomelatine (I) or its hydrates, crystalline forms and acid or base addition salts, to obtain a drug to treat Smith Magenis syndrome, is claimed. An independent claim is included for a composition comprising (I) optionally in combination with excipients. ACTIVITY : Antidepressant; Hypnotic; C...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MOCAER, ELIZABETH, FABIANO, AGNES
Format:	Patent
Sprache:	eng
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Use of agomelatine (I) or its hydrates, crystalline forms and acid or base addition salts, to obtain a drug to treat Smith Magenis syndrome, is claimed. An independent claim is included for a composition comprising (I) optionally in combination with excipients. ACTIVITY : Antidepressant; Hypnotic; Cardiovascular-Gen.; Anorectic. MECHANISM OF ACTION : 5-Hydroxytryptamine-2C antagonist; Melatoninergic receptor agonist.